GlassScriptPhysician profile
Hans P Steimann
NPI 1801069505
$4,949.02
in general payments reported to CMS, 2019-2025
20 companies · $718 in 2025
The $718 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $535 · 2021: $347 · 2022: $674 · 2023: $2,046 · 2024: $425 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132 · Travel and Lodging: $1,031 · Entertainment: $26.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,132.49 |
| Travel and Lodging | $1,030.52 |
| Entertainment | $26.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,610.14 | 2020-2025 | Dailies Total1, Precision 1, Total30 |
| Johnson & Johnson Vision Care, INC. | $716.44 | 2019-2025 | Acuvue |
| Sight Sciences, INC. | $388.02 | 2020-2024 | Tearcare System |
| Bausch & Lomb Americas INC. | $282.30 | 2024-2025 | Miebo, Xiidra, Alden Scleral Zenlens |
| Dompe US, INC. | $149.80 | 2021-2023 | Oxervate |
| Glaukos Corporation | $130.69 | 2020 | |
| Novartis Pharmaceuticals Corporation | $111.16 | 2019-2023 | |
| Optos, INC. | $100.83 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rxsight INC | $75.10 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Abb Con-Cise Optical Group LLC | $74.42 | 2023 | Contact Lens, Spectacle Lenses |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $64.87 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $38.47 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $37.15 | 2021 | |
| Eyevance Pharmaceuticals LLC | $35.24 | 2020-2021 | |
| Harrow Eye, LLC | $29.86 | 2025 | Vevye |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionix USA, INC | $28.33 | 2024 | Optical Coherence Tomography Hoct-1f |
| Allergan, INC. | $19.78 | 2021 | |
| Shire North American Group INC | $19.03 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.91 | 2020 | |
| Coopervision INC. | $18.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Steimann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.